# Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL

> **NCT06985498** · PHASE2 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 40 (estimated)

## Conditions studied

- Acute Lymphobkastic Leukemia

## Interventions

- **COMBINATION_PRODUCT:** Sandwich stratergy

## Key facts

- **NCT ID:** NCT06985498
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-06-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06985498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06985498, "Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06985498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*